In extensive experiments, the new AI model demonstrated a 32.37% relative improvement in the area under the precision-recall curve (PR-AUC) for Phase I clinical trials compared to the base HINT model.

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials. From patient ...

This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

Artificial intelligence (AI) is instrumental in solving several key clinical trial challenges. It can help in the synthesis and analysis of ever-expanding data for the development of innovative ...

Clinical trials are essential for licensing pharmaceutical products, so carrying them out requires operational excellence. Formulation development services are crucial for developing formulations and ...

Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in ...

The transfer of knowledge from animal models to humans is essential for unraveling disease mechanisms and developing precise ...

Finnish pharmaceutical company Orion has entered a partnership with Aitia to leverage artificial intelligence in drug ...

OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...

Evaxion and MSD have been collaborating on EVX-B3 since 2023. Also in 2023, MSD, through its Global Health Innovation Fund (MGHIF), led a private placement round of financing for Evaxion to become the ...